Search Results - M. S. Pokrovskaya

Refine Results
  1. 1

    Integration of pedagogical technologies developed for healthy and auditory impaired students by I. N. Lunina, M. V. Pokrovskaya, E. V. Rezchikova

    Published 2022-05-01

    The authors state that in a certain sense the learning problems of different groups of students (healthy and auditory impaired) are similar and can be solved by common pedagogical methods. The article presents the ways of integration of pedagogical technologies developedfor healthy and hearing-impai...

    Full description

    Get full text
    Article
  2. 2

    Risk management in biobanking by A. L. Borisova, M. S. Pokrovskaya, A. N. Meshkov, A. V. Kontsevaya, O. M. Drapkina

    Published 2022-12-01

    Risk management is a key aspect of the organization and management of biobanks, which is part of the overall quality management system aimed at early detection, analysis and minimization of events, that can lead to negative consequences for the biobank, as well as affect the quality of biosamples an...

    Full description

    Get full text
    Article
  3. 3

    The concept of the national information platform of biobanks of the Russian Federation by A. N. Meshkov, O. Yu. Yartseva, A. L. Borisova, M. S. Pokrovskaya, O. M. Drapkina

    Published 2022-12-01

    Aim. To create the concept of the national information platform of biobanks of the Russian Federation (NIPB RF).Material and methods. In April 2022, an expert group consisting of 17 representatives of Russian biobanks was formed in National Association of Biobanks and Biobanking Specialists to creat...

    Full description

    Get full text
    Article
  4. 4
  5. 5

    Role of biobanking in the development of personalized medicine in Russia and the world by M. S. Pokrovskaya, A. L. Borisova, A. V. Kiseleva, A. I. Ershova, A. N. Meshkov, O. M. Drapkina

    Published 2025-01-01

    To implement a modern personalized approach in practical healthcare, the latest biomedical technologies should be developed and genetic research should be performed. The analysis of a substantial quantity of data is essential for the investigation of the prevalence of genetic risk factors for variou...

    Full description

    Get full text
    Article
  6. 6

    Approaches to automation of the preanalytical phase of large-scale research in the biobank of the National Medical Research Center for Therapy and Preventive Medicine of the Minist... by M. S. Pokrovskaya, A. L. Borisova, V. A. Kondratskaya, I. A. Efimova, A. I. Ershova, O. M. Drapkina

    Published 2022-12-01

    Aim. To create and validate an algorithm for automatic aliquoting of serum and plasma samples for biobanking as part of a large-scale study.Material and methods. Biobank of the National Medical Research Center for Therapy and Preventive Medicine is equipped with a Tecan automated aliquoting system....

    Full description

    Get full text
    Article
  7. 7

    Influence of preanalytical variables on the quality of cell-free DNA. Biobanking of cell-free DNA material by V. A. Kondratskaya, M. S. Pokrovskaya, Yu. V. Doludin, A. L. Borisova, A. S. Limonova, А. N. Meshkov, O. M. Drapkina

    Published 2022-01-01

    The search for early disease markers and the development of diagnostic systems has recently been expanding within genomics. Genomic deoxyribonucleic acid (DNA), cell-free DNA (cfDNA) and microbiome DNA obtained from different types of samples (tissues, blood and its derivatives, feces, etc.) are use...

    Full description

    Get full text
    Article
  8. 8

    Biobanking in the hospital of a multidisciplinary research medical center as a potential for a wide research range. Part I. Organizational and methodological aspects by A. I. Borisova, O. V. Kopylova, M. S. Pokrovskaya, I. A. Efimova, A. V. Pustelenin, А. I. Ershova, O. M. Drapkina

    Published 2023-12-01

    Aim. To develop an algorithm and manage total biobanking of samples of whole blood, serum and plasma of patients in the hospital of the National Medical Research Center for Therapy and Preventive Medicine in order to create a detailed biosample collection through the integration of electronic medica...

    Full description

    Get full text
    Article
  9. 9

    Interaction of serum heat shock proteins’ levels with the severity of venous congestion in patients with acute decompensated heart failure with preserved ejection fraction by Yu. S. Timofeev, A. R. Afaunova, A. A. Ivanova, T. Yu. Vedenikin, O. N. Dzhioeva, V. A. Metelskaya, M. S. Pokrovskaya, O. M. Drapkina

    Published 2024-07-01

    Aim. To analyze the interactions between heat shock proteins (HSPs) (HSP27, HSP70 and cardiovascular HSP — cvHSP) serum levels and acute decompensated heart failure (HF) and signs of venous congestion in patients with preserved ejection fraction (HFpEF).Material and methods. The study included 80 pa...

    Full description

    Get full text
    Article
  10. 10

    Assessment of the frequency and association with morbidity of DNA markers in multinational administrative divisions based on indigenous population data (based on cardiovascular dis... by E. V. Balanovskaya, A. Yu. Potanina, S. M. Koshel, D. S. Adamov, I. V. Evsyukov, A. L. Borisova, M. S. Pokrovskaya, A. N. Meshkov

    Published 2025-01-01

    Information on morbidity is presented in statistical reports for the entire population of multinational subjects of Russia, but population Biobanks contain information on individual peoples.Aim. To develop a technology for assessing the frequency of deoxyribonucleic acid (DNA) markers for administra...

    Full description

    Get full text
    Article
  11. 11

    Premature coronary artery disease and severe hypertriglyceridemia in a patient with monogenic diabetes: a case report by V. I. Mikhailina, A. N. Meshkov, A. V. Kiseleva, A. I. Ershova, M. Zaichenoka, E. S. Luboyatnikova, M. S. Pokrovskaya, O. M. Drapkina

    Published 2023-11-01

    Aim. Maturity- onset diabetes of the young (MODY) is a group of monogenic diseases with an autosomal dominant inheritance. This is a rarely diagnosed disease, occurring in 1 of 10 thousand adults and in 1 of 23 thousand children. Brief description. We present a case report of a patient with a monoge...

    Full description

    Get full text
    Article
  12. 12

    Collection and storage of DNA-containing biomaterial and isolated DNA by Yu. V. Doludin, A. S. Limonova, V. A. Kozlova, A. I. Efimova, A. L. Borisova, A. N. Meshkov, M. S. Pokrovskaya, O. M. Drapkina

    Published 2020-12-01

    The advances of biomedicine include the new technologies, diagnosis and treatment techniques, as well as the practical use of new types of biological targets, in particular, nucleic acids. Genomic deoxyribonucleic acid (DNA), extracellular DNA (exDNA) and microbiome DNA obtained from different types...

    Full description

    Get full text
    Article
  13. 13

    Electronic medical records and biobanking by O. V. Kopylova, A. I. Ershova, I. A. Efimova, A. V. Blokhina, A. S. Limonova, A. L. Borisova, M. S. Pokrovskaya, O. M. Drapkina

    Published 2022-12-01

    Biosample preservation for future research is a fundamental component of translational medicine. At the same time, the value of stored biosamples is largely determined by the presence of related clinical data and other information. Electronic medical records are a unique source of a large amount of...

    Full description

    Get full text
    Article
  14. 14

    Relationship between gut microbiota and markers of myocardial fibrosis in with chronic heart failure with preserved ejection fraction by A. N. Kaburova, O. M. Drapkina, S. M. Yudin, S. N. Koretsky, V. V. Makarov, M. S. Pokrovskaya, S. A. Kraevoy, B. B. Shoybonov, I. A. Efimova

    Published 2021-07-01

    Aim. To study the relationship of gut microbiota (GM) with serum myocardial fibrosis markers in patients with heart failure with preserved ejection fraction (HFpEF).Material and methods. The composition of the gut microbiota among 42 patients with HFpEF aged 67,0 [64,0; 71,5] years (men, 57,1%) was...

    Full description

    Get full text
    Article
  15. 15

    COVID-19 incidence after vaccination with different types of vaccines against SARS-CoV-2 by O. M. Drapkina, S. A. Berns, M. G. Chashсhin, A. Yu. Gorshkov, O. V. Zhdanova, L. N. Ryzhakova, O. A. Litinskaya, M. S. Pokrovskaya

    Published 2025-02-01

    Until now, there remains a certain interest in studying the role of booster vaccination  in  the  formation  of  post-vaccination  immunity  against  the Severe  acute  respiratory  syndrome  coronavirus  2  (SARS-CoV-2).  The variety  of  vaccine  platforms  provides  the  opportunity  to  choose ...

    Full description

    Get full text
    Article
  16. 16

    Stability of serum biochemical markers during standard long-term storage and with a single thawing by V. A. Kozlova, V. A. Metelskaya, M. S. Pokrovskaya, I. A. Efimova, O. A. Litinskaya, V. A. Kutsenko, E. B. Yarovaya, S. A. Shalnova, O. M. Drapkina

    Published 2020-12-01

    Aim. To study the effect of standard serum long-term storage at -70О C and with a single thawing on the biochemical markers by comparing the results of studies carried out in 2013-2014 and 2020.Material and methods. The material was the blood serum of participants in the ESSE-RF study, which was sto...

    Full description

    Get full text
    Article
  17. 17

    Comparative assessment of the immunogenicity of various revaccination regimens against the SARS-CoV-2 by O. M. Drapkina, S. A. Berns, A. Yu. Gorshkov, L. N. Ryzhakova, O. V. Zhdanova, M. G. Chaschin, O. A. Litinskaya, A. A. Savicheva, M. S. Pokrovskaya

    Published 2023-01-01

    Along with efficacy and safety, it is extremely important to study the severity of humoral and cellular immunity during not only vaccination, but also revaccination against the Severe Acute Respiratory Syndromerelated CoronaVirus 2 (SARS-CoV-2).Aim. To compare the immunogenicity (humoral and cellula...

    Full description

    Get full text
    Article
  18. 18

    Heat shock proteins in the assessment of the course and prognosis of heart failure with preserved ejection fraction by Yu. S. Timofeev, T. Yu. Vedenikin, A. R. Afaunova, R. A. Zamyatin, V. A. Metelskaya, O. N. Dzhioeva, A. A. Ivanova, E. A. Neshkova, M. S. Pokrovskaya, O. M. Drapkina

    Published 2025-05-01

    Aim. To analyze the relationship between the concentrations of circulating heat shock proteins (HSP): HSP27, HSP70 and cardiovascular HSP (cvHSP) with the course of heart failure with preserved ejection fraction (HFpEF) and the outcomes of acute decompensated HFpEF (ADHFpEF).Material and methods. A...

    Full description

    Get full text
    Article
  19. 19

    A pilot project to study troponin I in a representative sample of the region from the ESSE-RF study: distribution among population and associations with risk factors by S. A. Shalnova, O. M. Drapkina, A. V. Kontsevaya, E. B. Yarovaya, V. A. Kutsenko, V. A. Metelskaya, A. V. Kapustina, Yu. A. Balanova, O. A. Litinskaya, M. S. Pokrovskaya

    Published 2021-07-01

    Aim. To assess the distribution of cardiac troponin I (cTnI) in a sample of the region from the ESSE-RF study and to study its associations with risk factors (RFs) and the Systematic Coronary Risk Evaluation (SCORE) system.Material and methods. This observational cross-sectional study includes a rep...

    Full description

    Get full text
    Article
  20. 20

    Pilot project to study the association of troponin I with cardiovascular events in the population of Russian region by S. A. Shalnova, O. M. Drapkina, A. V. Kontsevaya, E. B. Yarovaya, V. A. Kutsenko, V. A. Metelskaya, A. V. Kapustina, Yu. A. Balanova, O. A. Litinskaya, M. S. Pokrovskaya

    Published 2021-09-01

    Aim. As part of a pilot study, to investigate the potential significance of cardiac troponin I (cTnI) in assessing the risk of cardiovascular diseases (CVD) in general population aged 35-64 years of one of the regions from the ESSE-RF study.Material and methods. The study is based on the ESSE-RF obs...

    Full description

    Get full text
    Article